Entrada Therapeutics (TRDA) Amortizatization of Intangibles: 2022-2025
Historic Amortizatization of Intangibles for Entrada Therapeutics (TRDA) over the last 4 years, with Sep 2025 value amounting to $739,000.
- Entrada Therapeutics' Amortizatization of Intangibles fell 77.00% to $739,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 41.69%. This contributed to the annual value of $10.0 million for FY2024, which is 73.35% up from last year.
- As of Q3 2025, Entrada Therapeutics' Amortizatization of Intangibles stood at $739,000, which was down 23.10% from $961,000 recorded in Q2 2025.
- In the past 5 years, Entrada Therapeutics' Amortizatization of Intangibles registered a high of $3.2 million during Q3 2024, and its lowest value of -$145,000 during Q2 2022.
- In the last 3 years, Entrada Therapeutics' Amortizatization of Intangibles had a median value of $1.9 million in 2023 and averaged $1.7 million.
- As far as peak fluctuations go, Entrada Therapeutics' Amortizatization of Intangibles surged by 5,687.50% in 2023, and later plummeted by 77.00% in 2025.
- Over the past 4 years, Entrada Therapeutics' Amortizatization of Intangibles (Quarterly) stood at $104,000 in 2022, then spiked by 1,822.12% to $2.0 million in 2023, then rose by 25.41% to $2.5 million in 2024, then tumbled by 77.00% to $739,000 in 2025.
- Its Amortizatization of Intangibles was $739,000 in Q3 2025, compared to $961,000 in Q2 2025 and $1.3 million in Q1 2025.